Zyloprim Allopurinol

Allopurinol, widely known under the original brand name Zyloprim, is a medication primarily used to treat excess uric acid in the blood and its complications, including chronic gout. It was first developed by researchers Gertrude Elion and George Hitchings at Burroughs Wellcome & Company in the 1960s.

Over the decades, the pharmaceutical landscape has shifted through multiple mergers and acquisitions. Today, while generic versions are produced by numerous manufacturers globally, the original brand and its associated intellectual property are held by major multinational pharmaceutical groups. As of current market standings, companies like GSK and Organon (a spinoff from Merck & Co.) manage the distribution and brand rights in different territories.

Because it is an essential medication on the World Health Organization's List of Essential Medicines, allopurinol is manufactured in various facilities across several continents to ensure global supply chain stability.